Breaking News Instant updates and real-time market news.

ROK

Rockwell Automation

$241.20 /

-0.12 (-0.05%)

 18:22
11/17/20
 11/17
18:22
 11/17/20
18:22

Rockwell Automation CEO: Fiix is a really exciting acquisition for us

In an interview on CNBC's Mad Money, Blake Moret said Rockwell is currently working with many companies in developing and distributing a COVID-19 vaccine. Moret noted that oil and gas remains a big part of the automation market. "It's tough right now but I like our position," he added.

  • 17

    Nov

ROK Rockwell Automation
$241.20 /

-0.12 (-0.05%)

11/11/20 JPMorgan
Rockwell Automation guidance is 'aggressive', says JPMorgan
11/11/20 Credit Suisse
Rockwell Automation price target raised to $250 from $226 at Credit Suisse
11/11/20 Deutsche Bank
Rockwell Automation price target raised to $240 from $226 at Deutsche Bank
11/11/20 Barclays
Rockwell Automation price target raised to $274 from $250 at Barclays

TODAY'S FREE FLY STORIES

Earnings
ADT Inc. reports Q4 ex-items EPS (36c), consensus 31c » 16:26
02/25/21
02/25
16:26
02/25/21
16:26
ADT

ADT Inc.

$9.48 /

-0.77 (-7.51%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

02/23/21
ADT Inc., Dish partner to bring smart home security to more customers
02/18/21
ADT Inc., Hippo enter partnership for home insurance customers
02/16/21
Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel
02/10/21
Ackerman Security Systems joins ADT Authorized Dealer Program
ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

01/29/21 Citi
ADT Inc. downgraded to Neutral from Buy at Citi
01/29/21 Citi
ADT Inc. downgraded to Neutral from Buy at Citi
01/15/21 Deutsche Bank
ADT Inc. assumed with a Hold at Deutsche Bank
11/06/20 Roth Capital
Alarm.com price target raised to $75 from $65 at Roth Capital
ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

01/19/21
ADT Inc. reaffirms 2020 revenue view $5.2B-$5.35B, consensus $5.28B
11/05/20
ADT Inc. sees FY20 revenue $5.25B-$5.35B, consensus $5.23B
11/05/20
ADT Inc. reports Q3 ex-items EPS (8c), consensus 15c
  • 16
    Sep
ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

10/27/20
Foot Locker, DocuSign initiations among today's top calls on Wall Street
09/16/20
Fly Intel: Wall Street's top stories for Wednesday
09/16/20
Fly Intel: Wall Street's top stories at midday
09/16/20
Fly Intel: Pre-market Movers
17:00 Today
ADT Inc. - ADT
ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

14:35 Today
ADT put volume heavy and directionally bearish
01/08/21
ADT call volume above normal and directionally bullish
12/28/20
Unusually active option classes on open December 28th
12/10/20
Unusually active option classes on open December 10th
Hot Stocks
Edison International to provide guidance after CPUC adopts final decision » 16:26
02/25/21
02/25
16:26
02/25/21
16:26
EIX

Edison International

$55.62 /

-0.91 (-1.61%)

Edison International will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EIX Edison International
$55.62 /

-0.91 (-1.61%)

12/10/20
Edison International raises quarterly dividend to 66.25c from 63.75c per share
09/10/20
Portland General Electric drops as wildfires burn in Oregon, California
08/27/20
Southern California Edison approved for expanded EV charging program
EIX Edison International
$55.62 /

-0.91 (-1.61%)

01/06/21 Wells Fargo
Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
01/06/21 Wells Fargo
Edison International upgraded to Overweight from Equal Weight at Wells Fargo
11/18/20 Barclays
Edison International price target raised to $69 from $57 at Barclays
09/25/20 Mizuho
Edison International price target lowered to $63 from $67 at Mizuho
EIX Edison International
$55.62 /

-0.91 (-1.61%)

16:25 Today
Edison International reports Q4 adjusted EPS $1.19 consensus $1.20
10/27/20
Edison International narrows FY20 EPS view higher to $4.47-$4.62
10/27/20
Edison International reports Q3 EPS $1.67, consensus $1.49
EIX Edison International
$55.62 /

-0.91 (-1.61%)

09/23/20
Southern California Edison equipment probed as source of fire, AP says
16:30 Today
Edison International - EIX
Earnings
Everspin Technologies reports Q4 EPS (8c), two estimates (6c) » 16:26
02/25/21
02/25
16:26
02/25/21
16:26
MRAM

Everspin Technologies

$5.64 /

-0.35 (-5.84%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRAM Everspin Technologies
$5.64 /

-0.35 (-5.84%)

01/19/21
Everspin Technologies announces Sanjeev Aggarwal as CTO
12/15/20
Everspin Technologies falls 3% to $5.51 after resignation of CEO
12/15/20
Everspin Technologies CEO Kevin Conley to step down
17:00 Today
Everspin Technologies - MRAM
Earnings
WillScot Mobile Mini sees FY21 revenue $1.7B-$1.8B, consensus $1.71B » 16:26
02/25/21
02/25
16:26
02/25/21
16:26
WSC

WillScot Mobile Mini

$26.74 /

-0.89 (-3.22%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WSC WillScot Mobile Mini
$26.74 /

-0.89 (-3.22%)

02/16/21
Cooperman's Omega Advisors buys GM, exits Lee in Q4
WSC WillScot Mobile Mini
$26.74 /

-0.89 (-3.22%)

02/02/21 Deutsche Bank
WillScot Mobile Mini price target raised to $26 from $22 at Deutsche Bank
01/26/21 DA Davidson
WillScot Mobile Mini price target raised to $30 from $25 at DA Davidson
01/13/21 Oppenheimer
WillScot Mobile Mini price target raised to $29 from $24 at Oppenheimer
11/10/20 Barclays
WillScot Mobile Mini reinstated with an Equal Weight at Barclays
WSC WillScot Mobile Mini
$26.74 /

-0.89 (-3.22%)

16:25 Today
WillScot Mobile Mini reports Q4 revenue $437.65M, consensus $421.14M
11/05/20
WillScot Mobile Mini sees FY20 revenue $1.32B-$1.37B, down from $1.32B-$.42B
11/05/20
WillScot Mobile Mini reports Q3 EPS 7c, consensus 7c
WSC WillScot Mobile Mini
$26.74 /

-0.89 (-3.22%)

10/21/20
WillScot Mobile Mini pitched as long idea by Dendur's Mac Levine
02/26/21
WillScot Mobile Mini - WSC
05/18/21
WillScot Mobile Mini
Earnings
Collegium Pharmaceutical backs Xtampza ER revenue range$155M-$165M  16:25
02/25/21
02/25
16:25
02/25/21
16:25
COLL

Collegium Pharmaceutical

$26.04 /

-0.16 (-0.61%)

 
ShowHide Related Items >><<
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

02/12/21
Collegium Pharmaceutical to replace Iridium in S&P 600 at open on 2/12
02/08/21
Collegium Pharmaceutical to replace Iridium in S&P 600 at open on 2/12
01/06/21
Collegium Pharmaceutical sees FY21 adjusted EBITDA $160M-$170M
12/09/20
Synlogic appoints Collegium Pharmaceutical chairman Michael Heffernan to board
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

01/11/21 H.C. Wainwright
Collegium Pharmaceutical price target raised to $33 from $29 at H.C. Wainwright
12/29/20 Needham
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List
07/14/20 BWS Financial
Collegium Pharmaceutical initiated with a Sell at BWS Financial
05/27/20 Guggenheim
Guggenheim starts coverage of four pain treatment makers with two Buys
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

16:23 Today
Collegium Pharmaceutical reports Q4 EPS 20c, consensus 29c
11/05/20
Collegium Pharmaceutical reports Q3 EPS 32c, consensus 22c
16:30 Today
Collegium Pharmaceutical - COLL
03/05/21
Collegium Pharmaceutical
Earnings
Dell Technologies reports Q4 adjusted EPS $2.70, consensus $2.14 » 16:25
02/25/21
02/25
16:25
02/25/21
16:25
DELL

Dell Technologies

$79.76 /

-1.93 (-2.36%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DELL Dell Technologies
$79.76 /

-1.93 (-2.36%)

02/16/21
Elliott buys Evergy, exits eBay in Q4
11/24/20
Dell Technologies reports Q3 Infrastructure Solutions Group revenue $8B
11/24/20
Dell Technologies reports Q3 Client Solutions Group revenue $12.3B
11/24/20
Dell Technologies reports total deferred revenue of $28.7B at Q3-end
DELL Dell Technologies
$79.76 /

-1.93 (-2.36%)

02/24/21 JPMorgan
Dell Technologies price target raised to $90 from $85 at JPMorgan
02/23/21 Deutsche Bank
Dell Technologies price target raised to $94 from $81 at Deutsche Bank
02/11/21 Cleveland Research
Cleveland Research downgrades VMware to Neutral after checks with partners
02/02/21
Fly Intel: Top five analyst upgrades
DELL Dell Technologies
$79.76 /

-1.93 (-2.36%)

13:52 Today
Notable companies reporting after market close
11/24/20
Dell Technologies sees Q4 revenue up 3%-4% sequentially, consensus $23.09B
11/24/20
Dell Technologies reports Q3 adjusted EPS $2.03, consensus $1.40
11/24/20
Notable companies reporting after market close
DELL Dell Technologies
$79.76 /

-1.93 (-2.36%)

02/04/21
Boeing to outsource IT work to Dell, slash 600 jobs, AP reports
09/14/20
Dell Technologies plans to reduce workforce this week, Bloomberg reports
DELL Dell Technologies
$79.76 /

-1.93 (-2.36%)

02/02/21
Dell, Palo Alto upgrades among today's top calls on Wall Street
01/13/21
VMware slides as Gelsinger returns to Intel to be new CEO
11/25/20
Fly Intel: Wall Street's top stories for Wednesday
11/25/20
Fly Intel: Wall Street's top stories at midday
17:30 Today
Dell Technologies - DELL
DELL Dell Technologies
$79.76 /

-1.93 (-2.36%)

10/26/20
Dell Technologies put volume heavy and directionally bearish
Earnings
PTC Therapeutics reports Q4 EPS ($1.08), consensus (94c) » 16:25
02/25/21
02/25
16:25
02/25/21
16:25
PTCT

PTC Therapeutics

$55.34 /

-2.26 (-3.92%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PTCT PTC Therapeutics
$55.34 /

-2.26 (-3.92%)

02/17/21
PTC Therapeutics initiates second stage of Phase 2/3 trial of COVID-19 candidate
12/04/20
PTC Therapeutics: Translarna approved in Russia for treatment of nmDMD
11/30/20
PTC Therapeutics reports initiation of global Phase 3 Vatiquinone trial
11/25/20
Centogene expands partnership with PTC Therapeutics
PTCT PTC Therapeutics
$55.34 /

-2.26 (-3.92%)

02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
01/05/21 Citi
PTC Therapeutics upgraded to Buy from Neutral at Citi
11/30/20 RBC Capital
PTC Therapeutics downgraded to Underperform from Sector Perform at RBC Capital
PTCT PTC Therapeutics
$55.34 /

-2.26 (-3.92%)

10/29/20
PTC Therapeutics reports Q3 EPS ($1.03), consensus (6c)
PTCT PTC Therapeutics
$55.34 /

-2.26 (-3.92%)

09/23/20
Regenxbio slips as Novartis' Zolgensma expansion hits FDA roadblock
03/01/21
41st Annual Healthcare Virtual Conference
16:30 Today
PTC Therapeutics - PTCT
Earnings
Edison International reports Q4 adjusted EPS $1.19 consensus $1.20 » 16:25
02/25/21
02/25
16:25
02/25/21
16:25
EIX

Edison International

$55.62 /

-0.91 (-1.61%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EIX Edison International
$55.62 /

-0.91 (-1.61%)

12/10/20
Edison International raises quarterly dividend to 66.25c from 63.75c per share
09/10/20
Portland General Electric drops as wildfires burn in Oregon, California
08/27/20
Southern California Edison approved for expanded EV charging program
EIX Edison International
$55.62 /

-0.91 (-1.61%)

01/06/21 Wells Fargo
Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
01/06/21 Wells Fargo
Edison International upgraded to Overweight from Equal Weight at Wells Fargo
11/18/20 Barclays
Edison International price target raised to $69 from $57 at Barclays
09/25/20 Mizuho
Edison International price target lowered to $63 from $67 at Mizuho
EIX Edison International
$55.62 /

-0.91 (-1.61%)

10/27/20
Edison International narrows FY20 EPS view higher to $4.47-$4.62
10/27/20
Edison International reports Q3 EPS $1.67, consensus $1.49
EIX Edison International
$55.62 /

-0.91 (-1.61%)

09/23/20
Southern California Edison equipment probed as source of fire, AP says
16:30 Today
Edison International - EIX
Earnings
WillScot Mobile Mini reports Q4 revenue $437.65M, consensus $421.14M » 16:25
02/25/21
02/25
16:25
02/25/21
16:25
WSC

WillScot Mobile Mini

$26.74 /

-0.89 (-3.22%)

"Our WillScot Mobile…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WSC WillScot Mobile Mini
$26.74 /

-0.89 (-3.22%)

02/16/21
Cooperman's Omega Advisors buys GM, exits Lee in Q4
WSC WillScot Mobile Mini
$26.74 /

-0.89 (-3.22%)

02/02/21 Deutsche Bank
WillScot Mobile Mini price target raised to $26 from $22 at Deutsche Bank
01/26/21 DA Davidson
WillScot Mobile Mini price target raised to $30 from $25 at DA Davidson
01/13/21 Oppenheimer
WillScot Mobile Mini price target raised to $29 from $24 at Oppenheimer
11/10/20 Barclays
WillScot Mobile Mini reinstated with an Equal Weight at Barclays
WSC WillScot Mobile Mini
$26.74 /

-0.89 (-3.22%)

11/05/20
WillScot Mobile Mini sees FY20 revenue $1.32B-$1.37B, down from $1.32B-$.42B
11/05/20
WillScot Mobile Mini reports Q3 EPS 7c, consensus 7c
WSC WillScot Mobile Mini
$26.74 /

-0.89 (-3.22%)

10/21/20
WillScot Mobile Mini pitched as long idea by Dendur's Mac Levine
02/26/21
WillScot Mobile Mini - WSC
05/18/21
WillScot Mobile Mini
Conference/Events
Jefferies investment analysts to hold analyst/industry conference call » 16:25
02/25/21
02/25
16:25
02/25/21
16:25

Investment Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial
Conference/Events
Cowen cross asset analyst to hold an analyst/industry conference call » 16:25
02/25/21
02/25
16:25
02/25/21
16:25

Cross Asset Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Quaker Houghton sees FY21 adjusted EBITDA up over 20% vs. $222M in FY20  16:24
02/25/21
02/25
16:24
02/25/21
16:24
KWR

Quaker Houghton

$296.40 /

+1.4 (+0.47%)

 
ShowHide Related Items >><<
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

16:22 Today
Quaker Houghton CEO Michael Barry to retire
11/05/20
Quaker Houghton expects FY20 adjusted EBITDA to exceed $215M
09/16/20
Quaker Houghton raises quarterly dividend 2.6% to 39.5c per share
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

16:23 Today
Quaker Houghton reports Q4 adjusted EPS $1.63, consensus $1.52
11/05/20
Quaker Houghton reports Q3 adj. EPS $1.56, consensus 94c
03/11/21
Specialty Chemicals Virtual Conference
02/26/21
Quaker Houghton - KWR
Downgrade
Verra Mobility downgraded to Equal Weight from Overweight at Morgan Stanley » 16:24
02/25/21
02/25
16:24
02/25/21
16:24
VRRM

Verra Mobility

$14.15 /

-0.75 (-5.03%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

01/22/21
Verra Mobility acquires Redflex Holdings for A$146.1M
10/06/20
Verra Mobility to deploy CrossingGuard with three New York counties
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

02/12/21 BTIG
Verra Mobility price target raised to $18 from $15 at BTIG
01/22/21 William Blair
Verra Mobility acquisition should drive 15% share upside, says William Blair
11/24/20 BTIG
Verra Mobility price target raised to $15 from $13 at BTIG
11/23/20 Deutsche Bank
Verra Mobility price target raised to $13 from $12 at Deutsche Bank
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

11/05/20
Verra Mobility reports Q3 EPS 4c, consensus (2c)
03/01/21
Verra Mobility - VRRM
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

12/08/20
Unusual call flow in option market yesterday
12/07/20
Call spread buyer in Verra Mobility adding to position
Hot Stocks
Clearwater Paper: Demand for tissue products to be 'volatile' due to Covid-19 » 16:24
02/25/21
02/25
16:24
02/25/21
16:24
CLW

Clearwater Paper

$41.77 /

-1.305 (-3.03%)

"For the first…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

02/17/21
Clearwater Paper suspends Arkansas operations due to severe weather
11/04/20
Clearwater Paper falls -10.8%
08/31/20
Orion Engineered CAO Andre Isfort to depart, Bob Hrivnak to succeed
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

01/21/21 BMO Capital
Clearwater Paper initiated with an Outperform at BMO Capital
05/07/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform at RBC Capital on 'clear tailwinds'
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

16:23 Today
Clearwater Paper reports Q4 adjusted EPS $1.45 consensus $1.53
12/21/20
Clearwater Paper raises Q4 adj. EBITDA view to $71M-$76M from $52M-$62M
11/03/20
Clearwater Paper sees Q4 adj. EBITDA $52M-$62M vs. $20.2M last year
11/03/20
Clearwater Paper sees tissue product demand softening in Q4
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

11/03/20
Fly Intel: After-Hours Movers
17:00 Today
Clearwater Paper - CLW
03/09/21
Clearwater Paper
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

11/03/20
ClearWater Paper options imply 11.8% move in share price post-earnings
Earnings
Dicerna reports FY20 EPS ($1.52), consensus ($1.05) » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
DRNA

Dicerna

$28.14 /

+0.11 (+0.39%)

Reports FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRNA Dicerna
$28.14 /

+0.11 (+0.39%)

02/11/21
Dicerna initiates dosing in clinical trial of nedosiran for PH3
01/05/21
Dicerna announces first Novo Nordisk nominated candidate under agreement
01/04/21
Dicerna reports enrollment completion of PHYOX2 nedosiran trial
11/16/20
Dicerna gets $10M milestone from Lilly pact, Lilly initiates LY3561774 trial
DRNA Dicerna
$28.14 /

+0.11 (+0.39%)

01/11/21 B. Riley Securities
Dicerna price target raised to $37 from $30 at B. Riley Securities
08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
DRNA Dicerna
$28.14 /

+0.11 (+0.39%)

11/05/20
Dicerna reports Q3 EPS (29c), consensus (20c)
03/01/21
41st Annual Healthcare Virtual Conference
16:30 Today
Dicerna - DRNA
Hot Stocks
Evolent Health's Evolent Care Partners network adds two physician groups » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Evolent Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/13/21
Evolent Health: Bright HealthCare to acquire True Health New Mexico
12/22/20
Evolent Health enters into a cooperation agreement with Engaged Capital
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

16:21 Today
Evolent Health sees Q1 revenue $205M-$215M, consensus $229.29M
16:20 Today
Evolent Health sees 2021 revenue $830M-$880M, consensus $940.38M
16:19 Today
Evolent Health reports Q4 adjusted EPS (1c), consensus (5c)
11/05/20
Evolent Health sees Q4 adjusted revenue $249.0M-$264.0M, consensus $266.64M
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

10/08/20
Rent-A-Center, Evolent pitched at long ideas by Engaged's Welling
08/28/20
Evolent Health has seen strategic interest over last two years, Deal.com says
03/01/21
41st Annual Healthcare Virtual Conference
17:00 Today
Evolent Health - EVH
03/05/21
Evolent Health
Earnings
Quaker Houghton reports Q4 adjusted EPS $1.63, consensus $1.52 » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
KWR

Quaker Houghton

$296.40 /

+1.4 (+0.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

16:22 Today
Quaker Houghton CEO Michael Barry to retire
11/05/20
Quaker Houghton expects FY20 adjusted EBITDA to exceed $215M
09/16/20
Quaker Houghton raises quarterly dividend 2.6% to 39.5c per share
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

11/05/20
Quaker Houghton reports Q3 adj. EPS $1.56, consensus 94c
03/11/21
Specialty Chemicals Virtual Conference
02/26/21
Quaker Houghton - KWR
Earnings
Collegium Pharmaceutical reports Q4 EPS 20c, consensus 29c » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
COLL

Collegium Pharmaceutical

$26.04 /

-0.16 (-0.61%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

02/12/21
Collegium Pharmaceutical to replace Iridium in S&P 600 at open on 2/12
02/08/21
Collegium Pharmaceutical to replace Iridium in S&P 600 at open on 2/12
01/06/21
Collegium Pharmaceutical sees FY21 adjusted EBITDA $160M-$170M
12/09/20
Synlogic appoints Collegium Pharmaceutical chairman Michael Heffernan to board
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

01/11/21 H.C. Wainwright
Collegium Pharmaceutical price target raised to $33 from $29 at H.C. Wainwright
12/29/20 Needham
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List
07/14/20 BWS Financial
Collegium Pharmaceutical initiated with a Sell at BWS Financial
05/27/20 Guggenheim
Guggenheim starts coverage of four pain treatment makers with two Buys
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

11/05/20
Collegium Pharmaceutical reports Q3 EPS 32c, consensus 22c
16:30 Today
Collegium Pharmaceutical - COLL
03/05/21
Collegium Pharmaceutical
Earnings
Clearwater Paper reports Q4 adjusted EPS $1.45 consensus $1.53 » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
CLW

Clearwater Paper

$41.77 /

-1.305 (-3.03%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

02/17/21
Clearwater Paper suspends Arkansas operations due to severe weather
11/04/20
Clearwater Paper falls -10.8%
08/31/20
Orion Engineered CAO Andre Isfort to depart, Bob Hrivnak to succeed
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

01/21/21 BMO Capital
Clearwater Paper initiated with an Outperform at BMO Capital
05/07/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform at RBC Capital on 'clear tailwinds'
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

12/21/20
Clearwater Paper raises Q4 adj. EBITDA view to $71M-$76M from $52M-$62M
11/03/20
Clearwater Paper sees Q4 adj. EBITDA $52M-$62M vs. $20.2M last year
11/03/20
Clearwater Paper sees tissue product demand softening in Q4
11/03/20
Clearwater Paper reports Q3 EPS $1.28, consensus $1.38
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

11/03/20
Fly Intel: After-Hours Movers
17:00 Today
Clearwater Paper - CLW
03/09/21
Clearwater Paper
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

11/03/20
ClearWater Paper options imply 11.8% move in share price post-earnings
Conference/Events
UBS restaurants analyst to hold analyst/industry conference call » 16:22
02/25/21
02/25
16:22
02/25/21
16:22

Restaurants Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial
Hot Stocks
Quaker Houghton CEO Michael Barry to retire » 16:22
02/25/21
02/25
16:22
02/25/21
16:22
KWR

Quaker Houghton

$296.40 /

+1.4 (+0.47%)

Quaker Houghton announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

11/05/20
Quaker Houghton expects FY20 adjusted EBITDA to exceed $215M
09/16/20
Quaker Houghton raises quarterly dividend 2.6% to 39.5c per share
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

11/05/20
Quaker Houghton reports Q3 adj. EPS $1.56, consensus 94c
03/11/21
Specialty Chemicals Virtual Conference
02/26/21
Quaker Houghton - KWR
Earnings
Floor & Decor reports Q4 EPS 54c, consensus 44c » 16:22
02/25/21
02/25
16:22
02/25/21
16:22
FND

Floor & Decor

$93.93 /

-3.605 (-3.70%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

10/29/20
Floor & Decor not guiding FY20
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

02/19/21
Fly Intel: Top five analyst upgrades
02/19/21 Piper Sandler
Floor & Decor upgraded to Overweight from Neutral at Piper Sandler
02/09/21 Wells Fargo
Floor & Decor price target raised to $120 from $105 at Wells Fargo
01/28/21 Telsey Advisory
Floor & Decor upgraded to Outperform from Market Perform at Telsey Advisory
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

10/29/20
Floor & Decor reports Q3 EPS 65c, consensus 40c
  • 11
    Aug
  • 20
    May
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

12/10/20
Goldman Sachs says buy Floor & Decor, sell Best Buy
10/29/20
Fly Intel: After-Hours Movers
03/11/21
2021 Consumer, Industrials, & TMT Investor Virtual Conference
17:00 Today
Floor & Decor - FND
03/05/21
Floor & Decor
Hot Stocks
Eventbrite sees modest pace of recovery in paid ticket volume, revenue in 1H » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EB

Eventbrite

$19.04 /

-1.82 (-8.72%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

09/16/20
Eventbrite says paid tickets grew 17% in August vs July
09/01/20
Zoom Video reports resignation of Chief Accounting Officer
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

12/16/20 JPMorgan
Eventbrite price target raised to $15 from $10 at JPMorgan
05/18/20
Fly Intel: Top five analyst upgrades
05/18/20 SunTrust
Eventbrite upgraded to Buy at SunTrust on valuation
05/18/20 SunTrust
Eventbrite upgraded to Buy from Hold at SunTrust
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

16:21 Today
Eventbrite reports Q4 EPS (22c) consensus (37c)
11/05/20
Eventbrite reports Q3 EPS (21c), consensus (41c)
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

11/09/20
Fly Intel: Wall Street's top stories for Monday
11/09/20
Fly Intel: Wall Street's top stories at midday
17:00 Today
Eventbrite - EB
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

09/03/20
Unusually active option classes on open September 3rd
Earnings
Eargo sees FY21 revenue $87M-$93M, consensus $87.73M » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EAR

Eargo

$61.13 /

-3.855 (-5.93%)

Sees FY21 fross margin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
EAR Eargo
$61.13 /

-3.855 (-5.93%)

16:19 Today
Eargo reports Q4 EPS (30c), consensus (21c)
01/11/21
Eargo sees FY20 revenue approximately $69M, consensus $64.63M
01/11/21
Eargo sees Q4 revenue $22.2M, consensus $17.78M
11/19/20
Eargo reports Q3 revenue $18.2M, consensus $18.14M
  • 16
    Oct
EAR Eargo
$61.13 /

-3.855 (-5.93%)

11/19/20
Fly Intel: After-Hours Movers
10/18/20
Opening Day: Array jumps after $1.05B IPO
16:30 Today
Eargo - EAR
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/20/21
Five new option listings on January 20th
Earnings
Evolent Health sees Q1 revenue $205M-$215M, consensus $229.29M » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Adjusted EBITDA is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/13/21
Evolent Health: Bright HealthCare to acquire True Health New Mexico
12/22/20
Evolent Health enters into a cooperation agreement with Engaged Capital
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

16:20 Today
Evolent Health sees 2021 revenue $830M-$880M, consensus $940.38M
16:19 Today
Evolent Health reports Q4 adjusted EPS (1c), consensus (5c)
11/05/20
Evolent Health sees Q4 adjusted revenue $249.0M-$264.0M, consensus $266.64M
11/05/20
Evolent Health backs 2020 adj. revenue view $1.0B-$1.01B, consensus $1.02B
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

10/08/20
Rent-A-Center, Evolent pitched at long ideas by Engaged's Welling
08/28/20
Evolent Health has seen strategic interest over last two years, Deal.com says
03/01/21
41st Annual Healthcare Virtual Conference
17:00 Today
Evolent Health - EVH
03/05/21
Evolent Health

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.